| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Mafrice Daniel | Chairman, President and CEO, Director | C/O REMORA CAPITAL CORP., 3200 WEST END AVENUE, SUITE 500, NASHVILLE | /s/ Daniel Mafrice | 21 Jan 2026 | 0002078141 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | Common Stock, par value $0.001 per share | Purchase | $57,000 | +5,711 | +20% | $9.98 | 33,651 | 02 Jan 2026 | By Equity Trust Company Cust FBO Daniel Mafrice | F1 |
| Id | Content |
|---|---|
| F1 | This amendment is being filed to update the disclosure in Table I, Columns 4 and 5 in the Form 4 previously filed on January 6, 2026 by the reporting person in order to disclose the amount of securities acquired, the price of securities and the amount of securities beneficially owned following Mr. Mafrice's $57,000 purchase of common stock. The net asset value of the common stock as of January 2, 2026 was determined on January 20, 2026 and is included in this amendment. When Mr. Mafrice's Form 4 was initially filed on January 6, 2026, the amount of securities to be acquired was not calculable. |